MedPath

Ferring Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ferringusa.com

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women

Phase 2
Completed
Conditions
Nocturia
Interventions
First Posted Date
2012-09-13
Last Posted Date
2013-08-23
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
178
Registration Number
NCT01684800
Locations
🇯🇵

Kanno Clinic, Osaka, Japan

🇯🇵

Naka Clinic, Osaka, Japan

🇯🇵

Ogikubo Ekimae Clinic, Tokyo, Japan

and more 33 locations

Study of the Cleavage of the Egg in Relation to the Stimulation Treatment

Completed
Conditions
Female Infertility
First Posted Date
2012-08-29
Last Posted Date
2017-08-28
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
356
Registration Number
NCT01674894
Locations
🇩🇰

Danish Fertility Clinic, Frederiksberg, Copenhagen, Denmark

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel

Phase 3
Completed
Conditions
Adult Male Hypogonadism
Interventions
First Posted Date
2012-08-15
Last Posted Date
2017-10-26
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
180
Registration Number
NCT01665599
Locations
🇨🇦

Private Practice and Clinical Research, North Bay, Ontario, Canada

🇺🇸

California Professional Research, Newport Beach, California, United States

🇺🇸

Medical Affiliated Research Cente, Huntsville, Alabama, United States

and more 16 locations

Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock

Phase 2
Completed
Conditions
Septic Shock
Interventions
First Posted Date
2012-06-06
Last Posted Date
2017-03-23
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
31
Registration Number
NCT01612676
Locations
🇧🇪

Erasme Hospital Free University of Brussels, Brussels, Belgium

🇧🇪

Saint-Luc University Hospital, Brussels, Belgium

🇧🇪

University Hospital Brussels, Brussels, Belgium

and more 1 locations

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

Phase 3
Completed
Conditions
Nocturia
Interventions
Drug: Placebo
First Posted Date
2012-03-13
Last Posted Date
2017-07-11
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
56
Registration Number
NCT01552343
Locations
🇺🇸

Accelovance, Peoria, Illinois, United States

🇺🇸

Radiant Research, Inc., San Antonio, Texas, United States

🇺🇸

Avail Clinical Research, LLC, DeLand, Florida, United States

and more 6 locations

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

Completed
Conditions
Nocturia
First Posted Date
2012-03-13
Last Posted Date
2016-05-24
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
4136
Registration Number
NCT01552395
Locations
🇨🇿

Soukromá ambulance, Benešov, Benešov, Czech Republic

🇨🇿

URIONTEGRITAS soukromá ambulance, Brno, Czech Republic

🇨🇿

Městská nemocnice Dvůr Králové nad Labem a.s., Dvůr Králové nad Labem, Czech Republic

and more 64 locations

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Completed
Conditions
Ulcerative Colitis
First Posted Date
2012-01-25
Last Posted Date
2013-10-21
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
568
Registration Number
NCT01517594
Locations
🇨🇿

Nemocnice s poliklinikou Ráj, Karviná, Czech Republic

🇨🇿

FN sv.Anna, Brno, Czech Republic

🇨🇿

Nemocnice Karlovy Vary, Karlovy Vary, Czech Republic

and more 27 locations

Mesalazine (PENTASA®) in Ulcerative Colitis

Completed
Conditions
Ulcerative Colitis
Interventions
Other: Mesalazine
First Posted Date
2012-01-25
Last Posted Date
2015-10-01
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
506
Registration Number
NCT01517607
Locations
🇩🇪

Investigational site, Marienstraße 6, Amberg, Germany

🇩🇪

Investigational site, Adam-Ries-Straße 57c, Annaberg-Buchholz, Germany

🇩🇪

Investigational site, Goethestraße 5, Ansbach, Germany

and more 146 locations

Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2011-12-14
Last Posted Date
2013-12-12
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
76
Registration Number
NCT01491971
Locations
🇺🇸

South Orange County Urology Research, Laguna Hills, California, United States

🇨🇦

Bramalea Medical Centre, Brampton, Ontario, Canada

🇺🇸

South Florida Medical Research, Aventura, Florida, United States

and more 12 locations

A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation

Phase 3
Completed
Conditions
Constipation
Interventions
First Posted Date
2011-11-18
Last Posted Date
2012-09-25
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
300
Registration Number
NCT01474499
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

🇨🇳

The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

🇨🇳

Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath